These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23354348)

  • 1. [A case of Crohn's disease having normal delivery after infliximab treatment during early pregnancy].
    Jang YW; Park YS; Kim SH; Jo YJ; Jo YK; Ahn SB; Seo YS; Hong YO
    Korean J Gastroenterol; 2013 Jan; 61(1):37-41. PubMed ID: 23354348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
    Brookes MJ; Green JR
    Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of late onset-acute tubulointerstitial nephritis with infliximab and mesalazine treatment in a patient with Crohn's disease.
    Yoo YJ; Chung SY; Gu DH; Ko GJ; Pyo HJ; Kwon YJ; Bak YT; Won NH
    Korean J Gastroenterol; 2014 May; 63(5):308-12. PubMed ID: 24870303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
    Bodini G; Giannini EG; De Maria C; Dulbecco P; Furnari M; Marabotto E; Savarino V; Savarino E
    Dig Liver Dis; 2017 Feb; 49(2):175-180. PubMed ID: 27864028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
    Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
    Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 9. Theory based analysis of anti-inflammatory effect of infliximab on Crohn's disease.
    Furuya Y; Ozeki T; Takayanagi R; Yokoyama H; Okuyama K; Yamada Y
    Drug Metab Pharmacokinet; 2007 Feb; 22(1):20-5. PubMed ID: 17329907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].
    Jung BY; Lee SH; Chung SK; Lee CK; Lee TH; Chung IK; Kim SJ; Cho HD
    Korean J Gastroenterol; 2012 Jun; 59(6):437-40. PubMed ID: 22735878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M; Wanitschke R; Helisch A; Bartenstein P; Galle PR; Neurath M
    Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review.
    Kashima S; Moriichi K; Ando K; Ueno N; Tanabe H; Yuzawa S; Fujiya M
    BMC Gastroenterol; 2021 Oct; 21(1):373. PubMed ID: 34641810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
    Diamanti A; Basso MS; Gambarara M; Papadatou B; Bracci F; Noto C; Castro M
    Int J Colorectal Dis; 2009 Jan; 24(1):19-25. PubMed ID: 18797887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in treatment of Crohn's disease: the Milan experience.
    Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G
    Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.